Browse studies

Find your next paid study

8 recruiting studies matching your filters

A Sequential Phase 2/3, Single-Arm, Open-Label Study in Adults Followed by a Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of APL2 in Adults and Adolescents With Focal Segmental Glomerulosclerosis

This is a sequential phase 2/3 study to evaluate the efficacy and safety of twice-weekly subcutaneous (SC) infusions of APL2 in patients diagnosed with FSGS. T…

FSGS

Estimated

~$10 – $8,750

Apellis Pharmaceuticals, Inc.NCT07213960

Phase 2

A Phase 2 Study to Evaluate the Safety and Efficacy of Atacicept in Multiple Autoimmune Glomerular Diseases (PIONEER)

A study to find how well atacicept works and how safe it is in participants with autoimmune kidney disease.

pMNIgANNephrotic Syndrome+2 more

Estimated

~$10 – $8,750

Vera Therapeutics, Inc.NCT06983028

Observational

Implementing Precision Medicine for Glomerular Diseases in the Nephrotic Syndrome Study Network (NEPTUNE)

NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial match…

Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more

Estimated

~$10 – $6,250

University of MichiganNCT04571658

Phase 1

Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRαβ+ T-cell/CD19+ B-cell Depletion for Patients Who Will Receive a Kidney Transplant (KT) From the Same HSCT/KT Donor

This is a single center, non-randomized, non-controlled open-label phase 1b/2a trial of performing sequential αβdepleted-HSCT and KT in patients requiring KT t…

SIODCystinosisFSGS+2 more

Estimated

~$10 – $7,500

Alice BertainaNCT05508009

Phase 3

A Pivotal Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of DMX-200 in Patients With Focal Segmental Glomerulosclerosis (FSGS) Who Are Receiving an Angiotensin II Receptor Blocker (ARB)

DMX-200 (repagermanium) is a C-C chemokine receptor type 2 (CCR2) inhibitor that, when administered concurrently with an ARB, is designed to inhibit recruitmen…

FSGS

Estimated

~$10 – $8,750

Dimerix Bioscience Pty LtdNCT05183646

Observational

Validation and Implementation of Diagnostic Techniques for the Detection of Circulating Factors in Patients With Autoimmune Podocytopathy

Nephrotic syndrome is a kidney condition that mainly affects children and is characterized by high levels of protein in the urine, low levels of protein in the…

Nephrotic Syndrome With Edema (Diagnosis)Minimal Change Nephrotic SyndromeFocal Segmental Glomerulosclerosis (FSGS)+1 more

Estimated

~$10 – $6,250

Meyer Children's Hospital IRCCSNCT07516964

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis (FSGS) and Minimal Change Disease (MCD)

The morbidity of recurrence of focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) after transplant is well-recognized and include conte…

Focal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more

Estimated

~$10 – $750

University of MichiganNCT05650619

Preparing a Clinical Outcomes Assessment Set for Nephrotic Syndrome

Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interview…

Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more

Estimated

~$10 – $750

University of MichiganNCT05505500